Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IMMUCELL CORP /DE/ICCC · Entity 6837 | Director | June 03, 2021 | June 07, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IMMUCELL CORP /DE/
Report date June 03, 2021 · Filed June 07, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.10 per shareSEC Table I · non-derivative | Direct | 514,003 |
Reported balance
After 2021-06-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-06-03 · Grant · Acquired 3,845 · Balance 514,003 F1: These holdings include 226,416 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild |
| Incentive Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.52 · Expires 2021-07-17 | Direct | 0 |
Reported balance
After 2021-06-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-06-03 · Disposition to issuer · Disposed 11,155 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: These holdings include 226,416 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2021 Filed Jun 7, 2021 17:48 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerIncentive Stock Options (Right to buy) · Derivative | 11,155 | $9.52 Strike: $9.52 | $106,195.60 |
DisclosureSEC source: 0001213900-21-031186 · ownership.xml · derivative · entry 2 ROTHSCHILD JONATHAN E · CIK 0001043218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,155 shares Expires 2021-07-17 Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 17:48 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | GrantCommon Stock, par value $0.10 per share | 3,845 | $7.08 | $27,222.60 |
DisclosureSEC source: 0001213900-21-031186 · ownership.xml · nonDerivative · entry 1 ROTHSCHILD JONATHAN E · CIK 0001043218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,003 F1 · balance_after: These holdings include 226,416 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 18:10 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | GrantIncentive Stock Options (Right to buy) · Derivative | 15,000 | $7.08 Strike: $7.08 | $106,200.00 |
DisclosureSEC source: 0001213900-18-003256 · doc4.xml · derivative · entry 1 ROTHSCHILD JONATHAN E · CIK 0001043218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-03-19 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.